| Model Number |
8667-40 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Cerebrospinal Fluid Leakage (1772); Seroma (2069)
|
| Date of Event |
07/18/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Information was received from a healthcare professional via company representative regarding a patient with an implantable pump containing fentanyl (2500 mcg/ml at 120.1 mcg/day) and clonidine (10 mcg/ml at 0.480 mcg/day).It was reported that cerebrospinal fluid (csf) started accumulating in pump pocket a few days after replacement of pump and insertion of new 8780 catheter surgery on (b)(6) 2026.The old catheter remained implanted.Patient presented at surgeons office a several times and had pocket drained with the expectation that origin of leak would seal up/heal on it's own.Took patient in for surgery on (b)(6) 2026 and removed old catheter and placed sutures around openings where it appeared that csf was leaking from intrathecal space.
|
| |
|
Event or Problem Description
|
|
Additional information was received from the company representative (rep) reporting that the catheter was discarded at the time of the event.
|
| |
|
Additional Manufacturer Narrative
|
|
Section d references the main component of the system.Other medical products in use during the event include: brand name ascenda; product id: 8780; (serial: (b)(6)); product type: 0184-catheter; implant date (b)(6) 2026.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|